Independent Director of Design Therapeutics Picks Up 88% More Stock [Yahoo! Finance]
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth [Yahoo! Finance]
Design Therapeutics, Inc. (NASDAQ: DSGN) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $4.00 price target on the stock.
Design Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Design Therapeutics, Inc. (NASDAQ: DSGN) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.